Focal-point scanning for dose delivery and optimization with focused laser-accelerated very-high-energy electron beams

  • Zhiyuan Guo ,
  • Y. Pi ,
  • Junwei Zhou ,
  • ,
  • Wenbo Zhang ,
  • Haiyang Wang ,
  • Yaping Qi ,
  • Xiaoming Guo ,
  • Yuhan Zhang ,
  • Bo Peng ,
  • Jianfei Hua ,
  • Yang Wan ,
  • Wei Lu

arXiv

Focused very-high-energy electron (VHEE) beams can produce localized dose enhancement at selected depths, but irradiation of a finite target requires coordinated control of multiple focal positions, incidence directions, and beam weights while limiting exposure of nearby organs at risk (OARs). We present Focal-Point Scanning (FPS), a dose delivery and optimization method developed for laser wakefield accelerator (LWFA)-driven VHEE beams. The method is based on a two-dipole focusing system that produces single-plane beam convergence and allows the focal position to be varied by changing the magnetic field strength. FPS distributes focal points throughout the planning target volume and determines focal-point-specific incidence sectors according to the geometry of nearby critical OARs. The method was evaluated using the AAPM TG119 C-shape benchmark and one previously treated lung radiotherapy case. At matched target coverage, FPS reduced the TG119 Core mean dose by approximately one half relative to parallel VHEE and intensity-modulated x-ray plans, approaching the single-field proton pencil-beam-scanning reference. In the lung case, FPS maintained target coverage comparable to the clinical volumetric modulated arc therapy reference while reducing the mean dose to every evaluated OAR; spinal-cord mean and maximum doses decreased by 93.2% and 87.2%, respectively. The evaluated OAR mean doses varied little across rms energy spreads of 0 to 10% and for a flat-top electron spectrum spanning 150 to 250 MeV. These results demonstrate that focal-point-specific angular selection can translate focused-beam physics into effective OAR sparing and support FPS as a planning strategy for broadband LWFA-VHEE radiotherapy.